Paul B. Watkins
- Pharmacology top 0.01%
- Oncology top 0.2%
- Molecular Biology top 2%
- Pediatrics, Perinatology and Child Health top 0.1%
- Epidemiology top 1%
- Co-authors
- Steven WrightonErin G. SchuetzPhilip S. GuzelianRobert J. FontanaKenneth E. ThummelKenneth S. LownMary F. PaineJoseph C. Kolars
- Topics
- Drug-Induced Hepatotoxicity and Protection (113 papers)Pharmacogenetics and Drug Metabolism (112 papers)Drug Transport and Resistance Mechanisms (76 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Paul B. Watkins
239 papers receiving 19.2k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Pharmacology 11.5k
- Oncology 6.2k
- Molecular Biology 3.5k
- Pediatrics, Perinatology and Child Health 3.2k
- Epidemiology 2.3k
Countries citing papers authored by Paul B. Watkins
This map shows the geographic impact of Paul B. Watkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul B. Watkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul B. Watkins more than expected).
Fields of papers citing papers by Paul B. Watkins
This network shows the impact of papers produced by Paul B. Watkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul B. Watkins. The network helps show where Paul B. Watkins may publish in the future.
Co-authorship network of co-authors of Paul B. Watkins
This figure shows the co-authorship network connecting the top 25 collaborators of Paul B. Watkins. A scholar is included among the top collaborators of Paul B. Watkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul B. Watkins. Paul B. Watkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 5 | |
| 3 | 25 | |
| 4 | 1 | |
| 5 | 40 | |
| 6 | 65 | |
| 7 | 40 | |
| 8 | 89 | |
| 9 | 89 | |
| 10 | 154 | |
| 11 | 368 | |
| 12 | 90 | |
| 13 | 8 | |
| 14 | 447 | |
| 15 | 4 | |
| 16 | The furocoumarin 6',7'-dihydroxybergamottin (DHB) accelerates CYp3A4 degradation via the ubiquitin-proteasomal pathway. | 6 |
| 17 | 16 | |
| 18 | 108 | |
| 19 | 1 | |
| 20 | 316 |
About Paul B. Watkins
Paul B. Watkins is a scholar working on Pharmacology, Hepatology and Oncology, having authored 246 papers that have together received 19.9k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (113 papers), Pharmacogenetics and Drug Metabolism (112 papers) and Drug Transport and Resistance Mechanisms (76 papers). The work is most often cited by research in Pharmacology (11.5k citations), Transplantation (976 citations) and Hepatology (1.9k citations). Paul B. Watkins has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Steven Wrighton, Erin G. Schuetz, Philip S. Guzelian, Robert J. Fontana, Kenneth E. Thummel, Kenneth S. Lown, Mary F. Paine, Joseph C. Kolars, Timothy J. Davern and José Serrano. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.